Table 1.
DNA Modification | Enzyme/Mark | Role | Targeted Genes or Functions | Model | Methods | References |
---|---|---|---|---|---|---|
DNA methylation | Negative role in NSCs differentiation to glia | Repression of astrogliogenesis (Stat3 binding element in Gfap promoter) | In vitro neuroepithelial cells | BS PCR on neuroepithelial cells | Takizawa et al. [85] | |
DNMT1 | Negative role in NPCs differentiation to glia | Control of the timing of astrogliogenesis by repression of astrocyte-specific genes (Gfap, Stat1) | Nestin-cre;Dnmt1flox NPCs | BS PCR on Nestin-cre;Dnmt1flox NPCs | Fan et al. [86] | |
Positive role in NSCs differentiation to glia | Repression of neuron-specific genes (Dlx1, Dlx2, Trb1) | Sox2-EGFP mice | WGBS on NS/PCs from Sox2-EGFP transgenic mice | Sanosaka et al. [84] | ||
DNMT1 | Positive role in NSCs specification to OPCs | Repression of neuron-specific (Ndrg4, Camk1, Ephb2) and astrocyte-specific (Aldh1l1, Pax6, Rfx4) genes | Olig1cre;Dnmt1flox mice | RNA-Seq and ERRBS on sorted neonatal OPCs and OLs, RNA-Seq on sorted Olig1cre;Dnmt1flox OPCs | Moyon et al. [91] | |
DNA demethylation | Positive role in ESCs transition to NSCs | Activation of transcription factors (Sox2, Sox21, Ascl1) | Sox2-EGFP mice | WGBS on NS/PCs from Sox2-EGFP transgenic mice | Sanosaka et al. [84] | |
Positive role in NSCs differentiation to glia | Activation of gliogenic promoters (NFI, Tcf3, Gfap, Kcnj10, Sox8) | |||||
Activation of gliogenic promoters (Stat3 binding site in Gfap promoter, Aldoc) | In vitro NPCs and astrocytes from mice | MIAMI and BS on NPCs and astrocytes | Hatada et al. [87] | |||
DNA hydroxymethylation | TET1 | Positive role in NSCs differentiation to OPCs | Activation of OL genes (Olig1, Sox10, Id2/4) | Olig1cre;Tet1flox mice | hMeDIP-Seq on in vitro neonatal NSCs and OPCs, RNA-Seq on in vitro Olig1cre;Tet1flox OPCs | Zhang et al. [92] |
Histone Modification | Enzyme/Mark | Role | Targeted Genes or Functions | Model | Methods | References |
Histone methylation | PRC2 (EZH2) (H3K27me3) | Positive role in NSCs differentiation to OPCs | In vitro primary cultures + Olineu + Ezh2 expression vector/shRNA | Sher et al. [94] | ||
Repression of neuronal (NeuroD2, Tlx3), astrocytic (Tal1), OL (Olig2, Pdgfra, Nkx2.2) genes | In vitro NSCs and OPCs + shRNA | ChIP-Seq on in vitro NSCs and OLs | Sher et al. [95] | |||
PRC2 (EED) (H3K27me3) | Positive role in astrocyte–OPC fate switch | Olig1cre;Eedflox and PdgfracreRT;Eedflox mice | Wang et al. [96] | |||
H3K27me3 | Positive role in NSCs differentiation to OPCs | Repression of global lineage alternative choice | In vitro OPCs; Cnp-EGFP mice | ChIP-Seq on in vitro OPCs and OLs (H3K27me3) | Liu et al. [97] | |
PRMT1 | Positive role in NSCs differentiation to OPCs | Nestin-cre;Prmt1flox mice | Hashimoto et al. [98] | |||
Histone (de)acetylation | CBP (H3K9/K14ac) | Positive role in NSCs differentiation | Sequential activation of promoters of neuronal (Tuba1a), astrocytes (Gfap), OL (Mbp) | In vitro cortical precursors + siRNA/inhibitors; cbp+/− mice | ChIP-qPCR on cbp+/− cortices | Wang et al. [99] |
HDACs | Positive role in oligodendrogenesis | In vivo HDAC inhibition in rats | Liu et al. [100] | |||
HDAC1/HDAC2 | Positive role in Shh-induced oligodendrogenesis | Repression of genes associated with Notch signaling (Hey1, Hey2) and Wnt signaling (Tbx3) | In vitro OPCs, Olineu cells + shRNA/inhibitors | ChIP on in vitro Olineu and GeneChip on in vitro OPCs | Wu et al. [101] | |
HDAC2 (H3K9deac) | Negative role in NSCs differentiation to OPCs | Repression of oligodendroglial differentiation genes (Sox10) in the presence of thyroid hormone | In vitro NSCs, Olineu, OPCs + siRNA/inhibitors | ChIP-Seq on in vitro NSCs | Castelo-Branco et al. [102] | |
HDAC3 | Positive role in astrocyte–OL fate switch | Activation of enhancers of OPC genes (Olig2, Ng2) and repression of astrogliogeneis genes (Stat3) and neuronal genes (Bdnf) | In vitro astrocytes and OPCs + inhibitors/expression vectors; Olig1Cre;Hdac3flox, PDGFRaCreERT2;Hdac3flox; Syn1Cre;Hdac3flox mice | ChIP-Seq on in vitro OPCs and OL; RNA-Seq on optic nerves from Olig1cre;Hdac3flox mice | Zhang et al. [103] | |
SIRT1 (H3K9deac) | Negative role in NSCs differentiation to OPCs | Repression of differentiation to OPCs (deacetylation at the Pdgfrα promoter) | In vitro OPCs, NS/PCs + inhibitors; NestinCre;Sirt1flox mice | ChIP-qPCR on in vitro NS/PCs | Rafalski et al. [104] | |
Chromatin Organization | Enzyme/Mark | Role | Targeted Genes or Functions | Model | Methods | References |
Chromatin remodelers | HMGA1, 2 | Negative role in NPCs differentiation to glia | Repression of astrogenic transition | In vitro and in vivo NPCs + shRNA/overexpression | Kishi et al. [105] | |
HMGB1, 2, 3, 4 | Dynamically expressed in NSCs | In vitro NSCs, Nestin-GFP mice, HMGB2−/− mice | IHC, qPCR, shotgun proteomics on in vitro NSCs | Abraham et al. [106] | ||
HMGB2 | Possible role in NSCs proliferation and maintenance | In vitro NSCs, Nestin-GFP mice, HMGB2−/− mice | IHC, qPCR, shotgun proteomics on in vitro NSCs | Abraham et al. [106] | ||
Role in neuron–glia fate switch | In vitro NS/PCs, HMGB2−/− mice | Bronstein et al. [107] | ||||
HMGB4 | Negative role in NSCs differentiation to OPCs | Regulation of neuronal, astrocyte, oligodendrocyte genes (Fabp7, NeuroD1, Gfap, Ppp1r14a) | In vitro neurons, neurospheres and various cell lines + lentivirus; HMGB4 Vivo-Morpholinos | Microarray on HMGB4-EGFP over-expressing HEK 293T cells | Rouhiainen et al. [108] | |
HMGN family | Positive role in neuron–glia fate switch | Modulation of the response to gliogenic signals | In vitro NPCs + shRNA/overexpression | qPCR, IHC, BS and microarray on in vitro NPCs | Nagao et al. [109] | |
BRG1 | Positive role in NSCs maintenance and gliogenesis | Repression of neuronal differentiation in NSCs | In vitro NSCs, NestinCre;Brg1flox mice | IHC; DNA microarray on CNS tissues of NestinCre;Brg1flox mice | Matsumoto et al. [110] | |
Positive role in NSCs differentiation to neurons | Activation of neuronal genes (Ngn and NeuroD) | In vitro pluriopotent P19 cells + plasmids, Xenopus + Brg1 morpholino | IHC | Seo at al. [111] | ||
Limited role in NSCs | zebrafish + Brg1 morpholino | IHC, ISH | Gregg et al. [112] | |||
Post-Transcriptional Modification | Enzyme/Mark | Role | Targeted Genes or Functions | Model | Methods | References |
Long non-coding RNA | lnc-158 | Positive role in NSCs differentiation to OPCs | Activation of OL genes (Cnp, Mbp, Mag, Osp) | In vitro NSCs + lnc-158 overexpression and siRNA | Li et al. [113] | |
lnc-OPC | Positive role in NSCs differentiation to OPCs | Activation of OL genes (Mbp, Plp1, Cnp) | NSCs + shRNA | ChIP-Seq and RNA-Seq on in vitro NSCs | Dong et al. [114] | |
Neat1 | Positive role in NSCs differentiation to OPCs | Activation of OL genes (Olig1, Olig2, Gpr17, Sox8) | Neat1−/− mice | ChIP-Seq on human tissues; RNA-Seq on Neat1−/− mouse brains | Katsel et al. [115] | |
Sox8OT | Possible role in NSCs differentiation to OPCs | Via Sox8 activation | Descriptive study | Mercer et al. [116] | ||
MicroRNA | miR-124 | Positive role in NSCs differentiation to neurons | Repression of Ezh2 expression | In vitro NSCs + N2a neuroblastoma + P19 cells + overexpression | Microarray on N2a cells | Neo et al. [117] |
miR-153 | Negative role in NSCs differentiation to glia | Repression of gliogenic genes (Nfia/b) | In vitro ESCs + shRNA + artifical miRNAs | Tsuyama et al. [118] | ||
miR-17/106 | Positive role in NSCs differentiation to glia | Activation of gliogenesis (p38) | in vitro ESCs and mouse embryos + lentivirus | Naka-Kaneda et al. [119] |
BS: bisulfite sequencing, ChIP: chromatin immunoprecipitation, ERRBS: enhanced reduced representation bisulfite sequencing, hMeDIP-Seq: hMeDIP: hydroxyMethylated DNA immunoprecipitation; IHC: immunohistochemistry; ISH: in situ hybridization; NPCs: neural precursor or progenitor cells, NS/PCs: neural stem/progenitor cells; MIAMI: microarray-based integrated analysis of methylation by isoschizomers, qPCR: quantitative polymerase chain reaction; Seq: sequencing, WGBS: whole-genome bisulfite sequencing.